InflaRx
-$0.29 (-7.61%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.
About IFRX
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Its products include IFX-1 and IFX-2.
CEO
Niels Christoph Riedemann
Employees
49
Headquarters
Jena, Thueringen
Founded
2007
IFRX Key Statistics
Market cap
155.54M
Price-Earnings ratio
—
Dividend yield
—
Average volume
229.52K
High today
$3.67
Low today
$3.48
Open price
$3.64
Volume
258.89K
52 Week high
$6.38
52 Week low
$2.23
Analyst ratings
57%
of 7 ratings
Buy
57.1%
Hold
14.3%
Sell
28.6%
IFRX Earnings
-$0.42
-$0.28
-$0.14
-$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 24, Pre-Market